Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1949 1
1954 1
1955 3
1956 2
1957 1
1959 1
1960 2
1961 3
1962 9
1963 10
1964 7
1965 5
1966 13
1967 12
1968 22
1969 11
1970 14
1971 22
1972 11
1973 17
1974 16
1975 17
1976 12
1977 17
1978 18
1979 17
1980 20
1981 22
1982 29
1983 29
1984 42
1985 50
1986 39
1987 45
1988 62
1989 66
1990 60
1991 75
1992 90
1993 107
1994 116
1995 100
1996 98
1997 78
1998 81
1999 77
2000 115
2001 126
2002 135
2003 160
2004 149
2005 177
2006 175
2007 159
2008 135
2009 159
2010 180
2011 206
2012 200
2013 239
2014 263
2015 232
2016 273
2017 277
2018 296
2019 286
2020 342
2021 331
2022 337
2023 328
2024 258

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,454 results

Results by year

Filters applied: . Clear all
Page 1
Opioids for the management of dyspnea in cancer patients: a systematic review and meta-analysis.
Takagi Y, Sato J, Yamamoto Y, Matsunuma R, Watanabe H, Mori M, Hasegawa T, Matsuda Y, Kako J, Kasahara Y, Goya S, Kohara H, Nakayama T, Yamaguchi T. Takagi Y, et al. Among authors: hasegawa t. Int J Clin Oncol. 2023 Aug;28(8):999-1010. doi: 10.1007/s10147-023-02362-6. Epub 2023 Jun 20. Int J Clin Oncol. 2023. PMID: 37338727 Free PMC article. Review.
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity.
Lee CYC, Kennedy BC, Richoz N, Dean I, Tuong ZK, Gaspal F, Li Z, Willis C, Hasegawa T, Whiteside SK, Posner DA, Carlesso G, Hammond SA, Dovedi SJ, Roychoudhuri R, Withers DR, Clatworthy MR. Lee CYC, et al. Among authors: hasegawa t. Nat Commun. 2024 Jan 24;15(1):682. doi: 10.1038/s41467-024-44787-1. Nat Commun. 2024. PMID: 38267413 Free PMC article.
Mirror writing and cortical hypometabolism in Parkinson's disease.
Shinohara M, Yokoi K, Hirayama K, Kanno S, Hosokai Y, Nishio Y, Ishioka T, Otsuki M, Takeda A, Baba T, Aoki M, Hasegawa T, Kikuchi A, Narita W, Mori E, Suzuki K. Shinohara M, et al. Among authors: hasegawa t. PLoS One. 2022 Dec 14;17(12):e0279007. doi: 10.1371/journal.pone.0279007. eCollection 2022. PLoS One. 2022. PMID: 36516196 Free PMC article.
Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome.
Aiba I, Hayashi Y, Shimohata T, Yoshida M, Saito Y, Wakabayashi K, Komori T, Hasegawa M, Ikeuchi T, Tokumaru AM, Sakurai K, Murayama S, Hasegawa K, Uchihara T, Toyoshima Y, Saito Y, Yabe I, Tanikawa S, Sugaya K, Hayashi K, Sano T, Takao M, Sakai M, Fujimura H, Takigawa H, Adachi T, Hanajima R, Yokota O, Miki T, Iwasaki Y, Kobayashi M, Arai N, Ohkubo T, Yokota T, Mori K, Ito M, Ishida C, Tanaka M, Idezuka J, Kanazawa M, Aoki K, Aoki M, Hasegawa T, Watanabe H, Hashizume A, Niwa H, Yasui K, Ito K, Washimi Y, Mukai E, Kubota A, Toda T, Nakashima K; J-VAC study group. Aiba I, et al. Among authors: hasegawa t. Brain Commun. 2023 Nov 3;5(6):fcad296. doi: 10.1093/braincomms/fcad296. eCollection 2023. Brain Commun. 2023. PMID: 38090279 Free PMC article.
Identifying high-grade serous ovarian carcinoma-specific extracellular vesicles by polyketone-coated nanowires.
Yokoi A, Ukai M, Yasui T, Inokuma Y, Hyeon-Deuk K, Matsuzaki J, Yoshida K, Kitagawa M, Chattrairat K, Iida M, Shimada T, Manabe Y, Chang IY, Asano-Inami E, Koya Y, Nawa A, Nakamura K, Kiyono T, Kato T, Hirakawa A, Yoshioka Y, Ochiya T, Hasegawa T, Baba Y, Yamamoto Y, Kajiyama H. Yokoi A, et al. Among authors: hasegawa t. Sci Adv. 2023 Jul 7;9(27):eade6958. doi: 10.1126/sciadv.ade6958. Epub 2023 Jul 7. Sci Adv. 2023. PMID: 37418532 Free PMC article.
Plasma sphingolipid abnormalities in neurodegenerative diseases.
Oizumi H, Sugimura Y, Totsune T, Kawasaki I, Ohshiro S, Baba T, Kimpara T, Sakuma H, Hasegawa T, Kawahata I, Fukunaga K, Takeda A. Oizumi H, et al. Among authors: hasegawa t. PLoS One. 2022 Dec 16;17(12):e0279315. doi: 10.1371/journal.pone.0279315. eCollection 2022. PLoS One. 2022. PMID: 36525454 Free PMC article.
Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan.
Mukai R, Kataoka K, Tanaka K, Miyara Y, Maruko I, Nakayama M, Watanabe Y, Yamamoto A, Wakatsuki Y, Onoe H, Wakugawa S, Terao N, Hasegawa T, Hashiya N, Kawai M, Maruko R, Itagaki K, Honjo J, Okada AA, Mori R, Koizumi H, Iida T, Sekiryu T. Mukai R, et al. Among authors: hasegawa t. Sci Rep. 2023 May 30;13(1):8747. doi: 10.1038/s41598-023-35759-4. Sci Rep. 2023. PMID: 37253802 Free PMC article.
6,454 results